Consistently tracking KL-6 levels may help predict acute exacerbations in IPF and other types of fibrotic ILDs, a study ...

How do you want to be remembered after your passing? Columnist Sam Kirton shares the steps he's taking to leave a positive legacy.

GRI-0621 appears to reduce markers of fibrosis in people with idiopathic pulmonary fibrosis, interim clinical trial data ...

Columnist Sam Kirton finds that filling the silence is part of living with a chronic condition, especially amid retirement and COVID-19.

Researchers in China used machine learning to create diagnostic and prognostic models to aid in identifying idiopathic ...

Researchers in China used machine learning to create diagnostic and prognostic models to aid in identifying idiopathic pulmonary fibrosis.

Columnist Sam Kirton describes how daunting an IPF prognosis can be — but also how things are looking up for patients today.

IPF treatment candidate CS014 was safe and well tolerated in volunteers in a Phase 1 trial, and showed early promise for reversing scarring.

A flash flood can pose unique risks for PF patients, says columnist Sam Kirton, who shares several ways to prepare for such an emergency.